Across TCGA pan-cancer cohorts, LINC01657 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of LINC01657’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where LINC01657 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01657 is over-expressed in tumor, although a few such as STAD show the opposite, repressed pattern.

STAD and LUSC are the cancer types where LINC01657 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01657 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	IV	−0.055	.008	1	view →
LUSC	All	All	+0.004	.037	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: LINC01657 RNA expression & survival · all LINC01657 data types